Avidity Biosciences

Avidity Biosciences

Research, development, and manufacturing of drug candidates which include antibody-sirna complexes. Learn more

Launch date
Employees
Market cap
€4.5b
Enterprise valuation
€3.3b (Public information from Sep 2024)
San Diego California (HQ)
Authorizing premium user...